Primary outcomes for intervention group A versus group B
Crude OR (95% CI) | P value | Adjusted* OR (95% CI) | P value | |
Typhoid comes from mosquitoes | ||||
Intention-to-treat (n=385)† | ||||
Group A | 0.61 (0.39 to 0.96) | 0.039 | 0.46 (0.28 to 0.76) | 0.002 |
Group B | Reference | – | Reference | – |
Per-protocol (n=130) | ||||
Group A | 0.23 (0.08 to 0.73) | 0.012 | 0.15 (0.04 to 0.58) | 0.006 |
Group B | Reference | – | Reference | – |
As-treated (n=306) | ||||
Group A | 0.47 (0.27 to 0.82) | 0.008 | 0.33 (0.19 to 0.64) | 0.001 |
Group B | Reference | – | Reference | – |
Typhoid and malaria co-occur | ||||
Intention-to-treat (n=404)† | ||||
Group A | 0.65 (0.43 to 0.98) | 0.040 | 0.51 (0.33 to 0.81) | 0.004 |
Group B | Reference | – | Reference | – |
Per-protocol (n=133) | ||||
Group A | 0.43 (0.15 to 1.25) | 0.121 | 0.32 (0.09 to 1.09) | 0.069 |
Group B | Reference | – | Reference | – |
As-treated (n=311) | ||||
Group A | 0.55 (0.32 to 0.96) | 0.033 | 0.47 (0.26 to 0.84) | 0.011 |
Group B | Reference | – | Reference | – |
*Adjusted for sex, education, religion, income and age.
†Complete case analysis. Participants who responded ‘Don’t Know’ or ‘No Response’ in either baseline or endline were excluded.